Results 231 to 240 of about 22,218,716 (335)
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
An integrated approach for rare disease detection and classification in Spanish pediatric medical reports. [PDF]
Duque A +5 more
europepmc +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Exploration of the causal association between osteoarthritis and ankle-foot diseases: evidence from the Mendelian randomization and colocalization analysis. [PDF]
Tong X +7 more
europepmc +1 more source
Prevalence and Incidence of Cardiovascular Disease in 1160 Older Men and 2464 Older Women in a Long-term Health Care Facility [PDF]
Wilbert Aronow, Chul Ahn, Hal Gutstein
openalex +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Effectiveness of Virtual Home Health Care for Chronic Diseases Management: A Cross-Sectional Study Among the Saudi Population. [PDF]
Elsayed EA +3 more
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source

